Inventor
Catherine Leblanc
Inventor
Basel, CH
Overview
Patents· 33 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes24%
C02FTreatment of water, waste water, sewage, or sludge1%
C07BGeneral methods of organic chemistry1%
C07CAcyclic or carbocyclic compounds1%
C12NMicroorganisms or enzymes1%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
C12YEnzymes1%
PatentTitleYear
10,786,492Formylated N-heterocyclic derivatives as FGFR4 inhibitors202010,507,201Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors201910,189,813Formylated N-heterocyclic derivatives as FGFR4 inhibitors201910,130,629Pharmaceutical combinations20189,896,449'Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors'20189,802,917'Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide'20179,604,981'IP receptor agonist heterocyclic compounds'20179,533,988'Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors'20179,353,354'Bacterial iodoperoxidases from Zobellia galactanivorans, methods of preparation and uses thereof'20169,266,883'Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors'20169,174,985'Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists'20159,169,251'Pyrrolopyridine derivatives and their use as CRTH2 antagonists'20159,132,127'Substituted pyrido[2,3-B]pyrazines as IP receptor agonists'20159,115,129'Substituted pyrido[2,3-B]pyrazines as IP receptor agonists'20159,079,897'Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors'20159,073,932'Substituted pyrrolo[2,3-B]pyrazines for the treatment of disorders and diseases'20158,937,069'Substituted pyrrolo[2,3-B]pyrazine compounds and their use'20158,791,256'Pyrrolopyridine derivatives and their use as CRTH2 antagonists'20148,754,085'Pyrido[2,3-b]pyrazine compounds useful as IP receptor agonist'20148,470,848'Organic compounds'20138,455,645'Pyrrolopyridine derivatives and their use as CRTH2 antagonists'20138,431,578'Organic compounds'20138,431,703'Pyrrolopyridine compounds and their use in treating disease'20138,367,662'Organic compounds'20138,343,966'Organic compounds'20138,314,112'Pyrrolopyrimidines and pyrrolopyridines'20128,129,541'5-phenylthiazole derivatives and use as PI3 kinase inhibitors'20128,017,608'5-Phenylthiazole derivatives and their use as p13 kinase inhibitors'20117,989,458'Pyrimidine derivatives as alk-5 inhibitors'20117,902,375'5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseases'20117,687,637'5-phenylthiazole derivatives and use as Pi3 kinase inhibitors'20107,678,826'Organic compounds for the treatment of inflammatory or allergic conditions'20107,666,878'Pyrrolopyridine derivatives and their use as Crth2 antagonists'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2020Patents assigned to NOVARTIS AG (31)· patent assignee history
2010–2019Patents assigned to LEBLANC CATHERINE (20)· patent assignee history
2010–2015Based in Horsham, GB· patent location history
2010–2015Based in West Sussex, GB· patent location history
2014–2020Based in Basel, CH· patent location history
2016–2019Patents assigned to BUSCHMANN NICOLE (5)· patent assignee history
2016–2019Patents assigned to FAIRHURST ROBIN ALEC (5)· patent assignee history
2016–2019Patents assigned to FURET PASCAL (5)· patent assignee history
2016Based in Plougonven, FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 31 | 2010–2020 |
| LEBLANC CATHERINEself | 20 | 2010–2019 |
| BUSCHMANN NICOLE | 5 | 2016–2019 |
| FAIRHURST ROBIN ALEC | 5 | 2016–2019 |
| FURET PASCAL | 5 | 2016–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Basel, CH | 15 | 2014–2020 |
| Horsham, GB | 14 | 2010–2015 |
| West Sussex, GB | 3 | 2010–2015 |
| Plougonven, FR | 1 | 2016 |